3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Solid Malignant Tumors
1
Recurrence
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Glioblastoma
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cisplatin
6
pembrolizumab
4
durvalumab
4
Platinum
4
Carboplatin
4
1,2-diaminocyclohexaneplatinum II citrate
4
cemiplimab
3
Radiation
3
Paclitaxel
3
Cetuximab
3
Biopsy
3
(225)Ac-DOTA-c(RGDyK)
3
cabozantinib
2
atezolizumab
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Pemetrexed
2
Nivolumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
ALT-803
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
repotrectinib
1
poly ICLC
1
ipatasertib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
regorafenib
×
30 days
×
Clear all
No trials found.